Trial intelligence / Profile preview

Comparison of Seretide Evohaler vs Generic Salmeterol/Fluticasone in Asthma

NCT01795664Phase 3Completed

Sponsor
FLUIDDA
Start
Mar 2013
Primary completion
Aug 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of fluticasone propionate, salmeterol in asthma, sponsored by FLUIDDA. Started Mar 2013; status: completed.

02

Drugs

fluticasone propionatesalmeterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01795664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01795664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call